Binges and Neural Variability
BEDVAR
What is Driving the Binge in Binge Eating Disorder? Variability in Brain Response to Reward and the Escalation of Consumption
1 other identifier
observational
61
1 country
1
Brief Summary
People who suffer from binge eating disorder experience recurrent episodes of binge eating.During these episodes, they consume an unusually large amount of food in a short amount of time and experience loss of control over eating. However, why such binge eating episodes occur is still largely unknown. This makes it difficult to develop targeted treatments. In this project, the experimenters are investigating the brain mechanisms that give rise to the disorder. They hypothesize that the binge eating episodes are due to an increased variability in reward processing, which they will assess repeatedly over days. They will test this hypothesis using mathematical models based on behavioural and MRI measurements that are related to the processing of rewards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedStudy Start
First participant enrolled
December 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedAugust 11, 2021
April 1, 2021
1.5 years
October 29, 2019
August 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Variability in blood-oxygen-level dependent (BOLD) signalling in the NAcc during effort allocation task
Variability of BOLD signal in the nucleus accumbens (NAcc) over time and between trials while performing an effort allocation task. The signal is measured through functional magnetic resonance imaging (fMRI) and variability is determined through model residuals.
100 min
Trial-to-trial variability in reward seeking in an effort allocation task
Variability of performance is an intra-individual measure, that is defined by the residuals of a linear mixed effects model of trial-to-trial performance on the effort allocation task.
40 min
Variability in BOLD signalling in the NAcc for food-cue reactivity
Variability of BOLD signal in the NAcc between blocks of food pictures. The signal is measured through fMRI and variability is determined through model residuals.
15
Secondary Outcomes (1)
Variability in BOLD signalling in the NAcc during non-food-cue reactivity
5
Study Arms (3)
Binge eating disorder (BED) patients
Individuals with BED diagnosis.
non-BED controls
Individuals that do not experience binges
subsyndromal BED controls
individuals that experience binges but do not fulfill the requirements for BED diagnosis.
Interventions
(Imaging while) performing reward related tasks.
Eligibility Criteria
The control group will consist of residents of the general area around Tübingen, Germany. BED patients will be recruited mainly from the outpatient clinic of the Department of Clinical Psychology of Tübingen, Germany.
You may qualify if:
- Binge eating disorder diagnosis
- Subsyndromal binge eating (control)
You may not qualify if:
- high risk of suicide
- co-occurring psychotic, bi-polar disorders, alcohol/substance dependence within the past six months
- lack of capacity for consent
- medical disorders that would affect weight and ability to participate
- insufficient German language skills (assessment will be in German)
- taking medication that would affect weight
- irremovable metal attached to the body (e.g. piercings)
- irremovable medical devices (e.g. pacemakers)
- any trauma or surgery which may have left ferromagnetic material in the body
- large tattoos
- pregnancy
- claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- Else Kröner Fresenius Foundationcollaborator
Study Sites (1)
Psychological Institute, University of Tübingen
Tübingen, Deutschland (deu), 72070, Germany
Biospecimen
serum
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nils B Kroemer, Dr
University Hospital Tuebingen
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 29, 2019
First Posted
December 4, 2019
Study Start
December 6, 2019
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
August 11, 2021
Record last verified: 2021-04